sandimmun neoral 100 mg capsules
novartis israel ltd - ciclosporin - capsules - ciclosporin 100 mg - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation. endogenous uveitis. severe psoriasis above age 16 that did not respond to other treatment. atopic dermatitis in adults only up to 8 weeks for severe cases in which conventional therapy is ineffective or inappropriate. rheumatoid arthritis: severe cases in which standard treatments are ineffective or inappropriate. nephrotic syndrom type mcd (minimal change disease) in cases where conventional therapy has failed.
sandimmun neoral 25 mg capsules
novartis israel ltd - ciclosporin - capsules - ciclosporin 25 mg - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation. endogenous uveitis. severe psoriasis above age 16 that did not respond to other treatment. atopic dermatitis in adults only up to 8 weeks for severe cases in which conventional therapy is ineffective or inappropriate. rheumatoid arthritis: severe cases in which standard treatments are ineffective or inappropriate. nephrotic syndrom type mcd (minimal change disease) in cases where conventional therapy has failed.
sandimmune- cyclosporine capsule, liquid filled sandimmune- cyclosporine injection sandimmune- cyclosporine solution
novartis pharmaceuticals corporation - cyclosporine (unii: 83hn0gtj6d) (cyclosporine - unii:83hn0gtj6d) - cyclosporine 25 mg - sandimmune (cyclosporine) is indicated for the prophylaxis of organ rejection in kidney, liver, and heart allogeneic transplants. it is always to be used with adrenal corticosteroids. the drug may also be used in the treatment of chronic rejection in patients previously treated with other immunosuppressive agents. because of the risk of anaphylaxis, sandimmune injection (cyclosporine injection, usp) should be reserved for patients who are unable to take the soft gelatin capsules or oral solution. sandimmune injection (cyclosporine injection, usp) is contraindicated in patients with a hypersensitivity to sandimmune (cyclosporine) and/or cremophor® el (polyoxyethylated castor oil). although no adequate and well-controlled studies have been conducted in children, patients as young as 6 months of age have received the drug with no unusual adverse effects. clinical studies of sandimmune (cyclosporine) did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger patients. other reported clinical experience has not identified differences in responses between the elderly and younger patients. in general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.
neoral capsule
novartis pharmaceuticals canada inc - cyclosporine - capsule - 50mg - cyclosporine 50mg - immunosuppressive agents
apo-cyclosporine oral solution
apotex inc - cyclosporine - solution - 100mg - cyclosporine 100mg - immunosuppressive agents
sandimmun 25 milligram capsules, soft
novartis pharmaceuticals uk ltd - ciclosporin - capsules, soft - 25 milligram - calcineurin inhibitors
sandimmun 100 milligram capsules, soft
novartis pharmaceuticals uk ltd - ciclosporin - capsules, soft - 100 milligram - calcineurin inhibitors
sandimmun neoral 10mg capsule
novartis corporation (malaysia) sdn. bhd. - cyclosporin a -
sandimmun neoral capsule 25mg
novartis corporation (malaysia) sdn. bhd. - cyclosporin a -
sandimmun neoral capsule 100mg
novartis corporation (malaysia) sdn. bhd. - cyclosporin a -